Literature DB >> 15788131

Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro.

Chuan-hai Zhang1, Yi-fei Wang, Xin-jian Liu, Jia-Hai Lu, Chui-wen Qian, Zhuo-yue Wan, Xin-ge Yan, Huan-ying Zheng, Mei-ying Zhang, Sheng Xiong, Jiu-xiang Li, Shu-yuan Qi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15788131

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  21 in total

Review 1.  Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

Review 2.  Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.

Authors:  Moshe Rogosnitzky; Paul Okediji; Igor Koman
Journal:  Pharmacol Rep       Date:  2020-07-22       Impact factor: 3.024

3.  In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.

Authors:  Yu-Bing Zhou; Ya-Feng Wang; Yan Zhang; Li-Yun Zheng; Xiao-Ang Yang; Ning Wang; Jin-Hua Jiang; Fang Ma; De-Tao Yin; Chang-Yu Sun; Qing-Duan Wang
Journal:  Eur J Pharmacol       Date:  2012-02-24       Impact factor: 4.432

Review 4.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

5.  Natural compounds inhibiting the replication of Porcine reproductive and respiratory syndrome virus.

Authors:  Anbu K Karuppannan; Kan Xing Wu; Jia Qiang; Justin Jang-Hann Chu; Jimmy Kwang
Journal:  Antiviral Res       Date:  2012-04-03       Impact factor: 5.970

6.  In vitro anti-viral activity of the total alkaloids from Tripterygium hypoglaucum against herpes simplex virus type 1.

Authors:  Zhe Ren; Chuan-hai Zhang; Lian-jun Wang; Yun-xia Cui; Ren-bin Qi; Chong-ren Yang; Ying-jun Zhang; Xiao-yi Wei; Da-xiang Lu; Yi-fei Wang
Journal:  Virol Sin       Date:  2010-04-09       Impact factor: 4.327

7.  Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments.

Authors:  Nabab Khan; Xuesong Chen; Jonathan D Geiger
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

Review 8.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

9.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.

Authors:  Hua-Hao Fan; Li-Qin Wang; Wen-Li Liu; Xiao-Ping An; Zhen-Dong Liu; Xiao-Qi He; Li-Hua Song; Yi-Gang Tong
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

Review 10.  Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.

Authors:  Shruti Mukherjee; Dipita Bhattacharyya; Anirban Bhunia
Journal:  Biophys Chem       Date:  2020-08-11       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.